The Claim
Genetic deletion of p16 in a mouse model of PTHrP dysfunction increases trabecular and cortical bone volume by approximately 40–60% compared to PTHrP-mutant mice without p16 deletion, as measured by micro-CT, and enhances osteoblast activity and bone formation markers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with a specific genetic mutation affecting bone growth, removing the p16 gene results in higher bone density and increased activity of bone-forming cells.
See the scientific wording
In a mouse model of PTHrP dysfunction, genetic deletion of p16 increases trabecular and cortical bone volume by approximately 40–60% compared to PTHrP-mutant mice without p16 deletion, as measured by micro-CT, and improves osteoblast activity and bone formation markers.
When a genetic fault disrupts bone growth, it causes stress and damage in bone-building stem cells, making them stop dividing and become inactive. Removing the p16 gene lets these stem cells start dividing again, turn into bone-forming cells, and rebuild bone tissue more effectively.
What the research says
1 studyIn mice with a genetic problem that makes their bones weak, removing the p16 gene made their bones 40–60% denser and helped bone-building cells work better, making their bones stronger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.